MyChesCo on MSN

FDA Greenlights First Gene Therapy for Older SMA Patients, Raising Hope Nationwide

The U.S. Food and Drug Administration approved Itvisma, a new adeno-associated virus vector-based gene therapy for spinal ...
BioSpace

NervGen’s Peptide Achieves Nervous System Repair in Phase II Spinal Cord Injury Study

NervGen will meet with the FDA early next year to align on a regulatory path forward for NVG-291 in chronic spinal cord ...
Business Wire

Bioness Announces Availability and First Installations of the Vector Gait and Safety System

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness Inc. today announced international availability and the first U.S. installations of the Vector Gait and Safety System™. The System, first installed in June ...
Nature

Intracerebroventricular delivery of self-complementary adeno-associated virus serotype 9 to the adult rat brain

Gene therapy for the central nervous system is poised to become a powerful treatment for numerous neurological disorders. Adeno-associated viral vectors based on serotype 9 (AAV9) have proven ...
Nature

Foamy virus as a gene transfer vector to the central nervous system

In addition to its safety benefits, FV possesses several novel properties and characteristics essential for effective gene delivery. The FV life cycle is unique, in that single-stranded viral RNA is ...